India Vaccine Production
-
{
- All
- News
- Videos
-
India Gets New Vaccine Tools To Fight Tuberculosis In Adolescents: Not 'A Magic Bullet' But A Good Breakthrough
While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, with a large, independent Phase III clinical trial led, funded and sponsored by the Indian Council of Medical Research (ICMR).
-
No Shortage Of Anti-Rabies Vaccine, Rabies Immunoglobulin In India: Union Health Minister J P Nadda
Union Health Minister J P Nadda on Tuesday asserted that there is no shortage of Rabies Immunoglobulin (RIG) and Anti-Rabies Vaccine (ARV) in the country as supply far exceeds domestic demand.
-
Rajasthan Launches Massive 2-Crore Cattle Vaccination Drive to Stamp Out Foot Mouth Disease
Rajasthan launches FMD drive to vaccinate 2.32 crore cattle, aiming for disease-free state by 2030.
-
Your Age May Influence Antibody Production In Response To A Virus: Study
Age strongly influences antibody production against viruses, researchers find. A Nature Immunology study shows age, sex, and genetics shape immune responses, with implications for tailored treatments.
-
World Immunization Day 2025: Expanding Adult Vaccines To Guard India's Health
While childhood programs have progressed, adult vaccine coverage remains low in India. From influenza and pneumococcal to HPV and zoster, adult-vaccines can protect health, productivity and public welfare.
-
"Not Humanly Possible To...": Adar Poonawalla On Work Hours vs Productivity
Amid the nationwide debate on work-life balance after problematic remarks by some industry leaders, Adar Poonawalla, CEO of vaccine manufacturer Serum Institute, has said it is not humanly possible to be productive beyond a certain number of hours
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Will Bring Out List of Scams In Mumbai Civic Body During MVA Term: D Fadnavis
Devendra Fadnavis on Wednesday said when Prime Minister Narendra Modi was facilitating vaccine production in the country during the pandemic, the then-MVA government in the state was indulging in alleged scams.
-
Sharad Pawar Demands Bharat Ratna For Serum Institute Founder Cyrus Poonawalla
Praising the work done by the founder of the Serum Institute of India (SII), in the field of vaccine production, founder of Nationalist Congress Party (NCP) Sharad Pawar demanded that Cyrus Poonawalla be honoured with the Bharat Ratna award.
-
Serum Institute Restarts Production Of Covishield Vaccine After Cases Rise
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
Production Of Cervical Cancer Vaccine To Increase In 2024: Adar Poonawalla
A day after the first indigenously developed Human Papillomavirus vaccine against cervical cancer was launched, Serum Institute of India CEO Adar Poonawalla on Wednesday said the vaccine will be available in small quantity this year.
-
Cervical Cancer Vaccine To Be Launched In India Next Year: Adar Poonawalla
Serum Institute of India (SII) had to defer HPV vaccine production by two years due to the focus on Covid, and will start supplying small quantities of the dose to the Indian government in early 2023, a top official has said.
-
"People Fed Up Of Covid, Vaccines. I Am Also Fed Up": Adar Poonawalla
Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the production of Covishield vaccine starting December 2021.
-
Nasal Vaccines Could Be Beneficial In Controlling Covid: WHO
Nasal Covid-19 vaccines could help to bring the Covid-19 pandemic under control, the World Health Organization said Wednesday after homegrown products were approved in India and China.
-
Over Rs 900 Crore Contributed By Finance Ministry For Covid Vaccine: Official
The Union Finance Ministry contributed more than Rs 900 crore to COVID vaccine development under 'Mission COVID Suraskha' resulting in India becoming a leader in vaccine production, said a top official.
-
India Gets New Vaccine Tools To Fight Tuberculosis In Adolescents: Not 'A Magic Bullet' But A Good Breakthrough
While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, with a large, independent Phase III clinical trial led, funded and sponsored by the Indian Council of Medical Research (ICMR).
-
No Shortage Of Anti-Rabies Vaccine, Rabies Immunoglobulin In India: Union Health Minister J P Nadda
Union Health Minister J P Nadda on Tuesday asserted that there is no shortage of Rabies Immunoglobulin (RIG) and Anti-Rabies Vaccine (ARV) in the country as supply far exceeds domestic demand.
-
Rajasthan Launches Massive 2-Crore Cattle Vaccination Drive to Stamp Out Foot Mouth Disease
Rajasthan launches FMD drive to vaccinate 2.32 crore cattle, aiming for disease-free state by 2030.
-
Your Age May Influence Antibody Production In Response To A Virus: Study
Age strongly influences antibody production against viruses, researchers find. A Nature Immunology study shows age, sex, and genetics shape immune responses, with implications for tailored treatments.
-
World Immunization Day 2025: Expanding Adult Vaccines To Guard India's Health
While childhood programs have progressed, adult vaccine coverage remains low in India. From influenza and pneumococcal to HPV and zoster, adult-vaccines can protect health, productivity and public welfare.
-
"Not Humanly Possible To...": Adar Poonawalla On Work Hours vs Productivity
Amid the nationwide debate on work-life balance after problematic remarks by some industry leaders, Adar Poonawalla, CEO of vaccine manufacturer Serum Institute, has said it is not humanly possible to be productive beyond a certain number of hours
-
"We Disclosed All Rare Side-Effects": Covid Vaccine Maker Amid Safety Row
The Serum Institute - which manufactured the Covishield COVID-19 vaccine developed by British pharma giant AstraZeneca - stressed on Wednesday that all its product packaging had "disclosed all rare to very rare side-effects", including TTS.
-
Will Bring Out List of Scams In Mumbai Civic Body During MVA Term: D Fadnavis
Devendra Fadnavis on Wednesday said when Prime Minister Narendra Modi was facilitating vaccine production in the country during the pandemic, the then-MVA government in the state was indulging in alleged scams.
-
Sharad Pawar Demands Bharat Ratna For Serum Institute Founder Cyrus Poonawalla
Praising the work done by the founder of the Serum Institute of India (SII), in the field of vaccine production, founder of Nationalist Congress Party (NCP) Sharad Pawar demanded that Cyrus Poonawalla be honoured with the Bharat Ratna award.
-
Serum Institute Restarts Production Of Covishield Vaccine After Cases Rise
Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
-
Production Of Cervical Cancer Vaccine To Increase In 2024: Adar Poonawalla
A day after the first indigenously developed Human Papillomavirus vaccine against cervical cancer was launched, Serum Institute of India CEO Adar Poonawalla on Wednesday said the vaccine will be available in small quantity this year.
-
Cervical Cancer Vaccine To Be Launched In India Next Year: Adar Poonawalla
Serum Institute of India (SII) had to defer HPV vaccine production by two years due to the focus on Covid, and will start supplying small quantities of the dose to the Indian government in early 2023, a top official has said.
-
"People Fed Up Of Covid, Vaccines. I Am Also Fed Up": Adar Poonawalla
Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the production of Covishield vaccine starting December 2021.
-
Nasal Vaccines Could Be Beneficial In Controlling Covid: WHO
Nasal Covid-19 vaccines could help to bring the Covid-19 pandemic under control, the World Health Organization said Wednesday after homegrown products were approved in India and China.
-
Over Rs 900 Crore Contributed By Finance Ministry For Covid Vaccine: Official
The Union Finance Ministry contributed more than Rs 900 crore to COVID vaccine development under 'Mission COVID Suraskha' resulting in India becoming a leader in vaccine production, said a top official.
